Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2426407 | 1.00 | USP2 (0.35) | USP2NPSR1MEN1KMT2AHIF1A | |
| SCHEMBL2706115 | 0.87 | NPSR1 (0.35) | USP2NPSR1ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL2707257 | 0.87 | NPSR1 (0.35) | USP2NPSR1ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL2706119 | 0.87 | NPSR1 (0.35) | USP2NPSR1ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL4458950 | 0.84 | ALDH1A1 (0.43) | USP2NPSR1ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL4458952 | 0.84 | ALDH1A1 (0.43) | USP2NPSR1ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL2424997 | 0.82 | TBXAS1 (0.33) | USP2NPSR1 | |
| SCHEMBL2707782 | 0.82 | TTR (0.40) | USP2NPSR1ALDH1A1CYP3A4 | |
| SCHEMBL2707781 | 0.82 | TTR (0.40) | USP2NPSR1ALDH1A1CYP3A4 | |
| SCHEMBL2425000 | 0.82 | TBXAS1 (0.33) | USP2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2094650-B1 | USE OF CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | MANE FILS V (FR) | 2011-09-21 | — | — | EP | disclosed |
| US-20080138482-A1 | USE OF NEW CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | V. MANE FILS (FR) | 2008-06-12 | — | — | US | disclosed |
| EP-1930317-A1 | Use of campholenic derivatives as fragrant ingredients in perfumery and flavouring | V. Mane Fils (FR) | 2008-06-11 | — | — | EP | disclosed |
| EP-0801049-B1 | Cyclopentanebutanol derivatives as odorants | GIVAUDAN SA (CH) | 2001-11-21 | — | — | EP | disclosed |
| US-6239314-B1 | ORGANOLEPTIC COMPOUND | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2001-05-29 | — | — | US | disclosed |
| US-6235943-B1 | CYCLIC UNSATURATED ALDEHYDES OR KETONES | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2001-05-22 | — | — | US | disclosed |
| US-6162954-A | Odorants | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2000-12-19 | — | — | US | disclosed |
| US-5929291-A | SYNTHETIC PERFUME | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 1999-07-27 | — | — | US | disclosed |
| EP-0801049-A2 | Cyclopentanebutanol derivatives as odorants | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1997-10-15 | — | — | EP | disclosed |
| EP-0203528-B1 | CYCLOPENTENE DERIVATIVES AND THEIR USE AS ODORANTS | L. GIVAUDAN & CIE Société Anonyme (CH) | 1990-08-01 | — | — | EP | disclosed |
| US-4696766-A | FRAGRANCES | GIVAUDAN CORPORATION (US) | 1987-09-29 | — | — | US | disclosed |
| EP-0203528-A2 | Cyclopentene derivatives and their use as odorants | L. GIVAUDAN & CIE Société Anonyme (CH) | 1986-12-03 | — | — | EP | disclosed |
| US-4052341-A | 3-METHYL-5-(2,2,3-TRIMETHYLCYCLOPENT-3-EN-1-YL)PENTAN-2-OL COMPOUND AND PERFUME COMPOSITIONS | GIVAUDAN CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080138482-A1 | USE OF NEW CAMPHOLENIC DERIVATIVES AS FRAGRANT INGREDIENTS IN PERFUMERY AND FLAVOURING | C5, C3AR1, PDE6D | USP2 3867/4885NPSR1 2895/4885MEN1 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.